Trial intelligence / Profile preview

CRAMPP: Oral Contraceptives for Dysmenorrhea and Bladder Pain Risk

NCT02214550Phase 4Completed

Sponsor
Endeavor Health
Start
Jul 2014
Primary completion
Nov 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ethinyl estradiol in dysmenorrhea, interstitial cystitis (IC), sponsored by Endeavor Health. Started Jul 2014; status: completed.

02

Drugs

ethinyl estradiol
03

Conditions

dysmenorrheainterstitial cystitis (IC)

Beyond the preview

Go deeper on NCT02214550.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02214550.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call